ES2249058T3 - Factores de preservacion de celulas progenitoras y metodos y productos relacionados. - Google Patents

Factores de preservacion de celulas progenitoras y metodos y productos relacionados.

Info

Publication number
ES2249058T3
ES2249058T3 ES99967798T ES99967798T ES2249058T3 ES 2249058 T3 ES2249058 T3 ES 2249058T3 ES 99967798 T ES99967798 T ES 99967798T ES 99967798 T ES99967798 T ES 99967798T ES 2249058 T3 ES2249058 T3 ES 2249058T3
Authority
ES
Spain
Prior art keywords
cells
fril family
progeniting
products
family members
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99967798T
Other languages
English (en)
Inventor
M Gabriella Colucci
Maarten J Chrispeels
Jeffrey G Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California, San Diego
ImClone LLC
Original Assignee
ImClone Systems Inc
University of California Berkeley
University of California, San Diego
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ImClone Systems Inc, University of California Berkeley, University of California, San Diego filed Critical ImClone Systems Inc
Application granted granted Critical
Publication of ES2249058T3 publication Critical patent/ES2249058T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • C07K14/42—Lectins, e.g. concanavalin, phytohaemagglutinin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Botany (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)

Abstract

Utilización de una cantidad terapéuticamente eficaz de una composición que contiene una proteína FRIL que comprende la secuencia de aminoácidos presentada en la SEC ID nº 6 para la preparación de un medicamento destinado al tratamiento de un estado caracterizada por la actividad deplecionadora de las células progenitoras hematopoyéticas de un tratamiento quimioterapéutico o radioterapéutico o una combinación de un tratamiento quimioterapéutico y radioterapéutico, en la que la cantidad terapéuticamente eficaz de dicha composición alivia o reduce la actividad deplecionadora de las células progenitoras hematopoyéticas de dicho tratamiento en el paciente y en la que el medicamento se debe administrar antes del tratamiento radioterapéutico o quimioterapéutico; en la que el medicamento se debe administrar aproximadamente entre 5 días y aproximadamente 2 horas antes del tratamiento quimioterapéutico o radioterapéutico y se debe administrar diariamente.
ES99967798T 1999-12-30 1999-12-30 Factores de preservacion de celulas progenitoras y metodos y productos relacionados. Expired - Lifetime ES2249058T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/031307 WO2001049851A1 (en) 1999-12-30 1999-12-30 Progenitor cell preservation factors and related methods and products

Publications (1)

Publication Number Publication Date
ES2249058T3 true ES2249058T3 (es) 2006-03-16

Family

ID=22274423

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99967798T Expired - Lifetime ES2249058T3 (es) 1999-12-30 1999-12-30 Factores de preservacion de celulas progenitoras y metodos y productos relacionados.

Country Status (10)

Country Link
EP (1) EP1246919B1 (es)
JP (1) JP2003521900A (es)
CN (1) CN1406280A (es)
AT (1) ATE302848T1 (es)
AU (1) AU784361C (es)
CA (1) CA2395625A1 (es)
DE (1) DE69926920T2 (es)
ES (1) ES2249058T3 (es)
HK (1) HK1050027B (es)
WO (1) WO2001049851A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020132017A1 (en) 1996-12-09 2002-09-19 Moore Jeffrey G. Composition and method for preserving progenitor cells
JP4394350B2 (ja) 2001-01-09 2010-01-06 ベイラー リサーチ インスティテュート 対象における自己免疫疾患の治療法及びｉｎｖｉｔｒｏ診断アッセイ
WO2002067973A1 (en) * 2001-02-27 2002-09-06 Phylogix Llc Compositions and methods for protecting tissues and cells from damage, and for repairing damaged tissues
CN101415434A (zh) * 2003-11-12 2009-04-22 晨兴风险投资有限公司 用于治疗b细胞淋巴瘤和其它癌症的方法和组合物
WO2006110577A2 (en) * 2005-04-08 2006-10-19 Morningside Venture Investments Limited Use of fril proteins for reducing the production of pro-inflammatory cytokines
EP2108043A4 (en) 2007-01-18 2010-04-21 Suomen Punainen Risti Veripalv NEW METHODS AND REAGENTS FOR THE PRODUCTION OF CELLS
US11083190B2 (en) 2007-06-29 2021-08-10 Makoto Funaki Soft gel systems in modulating stem cell development
US9725689B2 (en) 2010-10-08 2017-08-08 Terumo Bct, Inc. Configurable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
JP6247472B2 (ja) * 2013-08-06 2017-12-13 日本メナード化粧品株式会社 幹細胞の未分化状態維持剤及び増殖促進剤
EP3068867B1 (en) 2013-11-16 2018-04-18 Terumo BCT, Inc. Expanding cells in a bioreactor
US11008547B2 (en) 2014-03-25 2021-05-18 Terumo Bct, Inc. Passive replacement of media
EP3198006B1 (en) 2014-09-26 2021-03-24 Terumo BCT, Inc. Scheduled feed
WO2017004592A1 (en) 2015-07-02 2017-01-05 Terumo Bct, Inc. Cell growth with mechanical stimuli
WO2017205667A1 (en) 2016-05-25 2017-11-30 Terumo Bct, Inc. Cell expansion
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
JP7393945B2 (ja) 2017-03-31 2023-12-07 テルモ ビーシーティー、インコーポレーテッド 細胞増殖
US12234441B2 (en) 2017-03-31 2025-02-25 Terumo Bct, Inc. Cell expansion
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP4314244B1 (en) 2021-03-23 2025-07-23 Terumo BCT, Inc. Cell capture and expansion
US12152699B2 (en) 2022-02-28 2024-11-26 Terumo Bct, Inc. Multiple-tube pinch valve assembly
CN114262683B (zh) * 2022-03-01 2022-06-17 中国科学院动物研究所 一种表达vegfr3 d2多肽的细菌制剂及其构建方法和应用
USD1099116S1 (en) 2022-09-01 2025-10-21 Terumo Bct, Inc. Display screen or portion thereof with a graphical user interface for displaying cell culture process steps and measurements of an associated bioreactor device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6455678B1 (en) * 1996-04-26 2002-09-24 Amcell Corporation Human hematopoietic stem and progenitor cell antigen
US6084060A (en) * 1996-12-09 2000-07-04 Imclone Systems Incorporated Composition and method for preserving progenitor cells
US6310195B1 (en) * 1997-06-24 2001-10-30 Imclone Systems Incorporated Nucleic acid encoding a lectin-derived progenitor cell preservation factor

Also Published As

Publication number Publication date
HK1050027B (en) 2006-04-13
EP1246919B1 (en) 2005-08-24
HK1050027A1 (en) 2003-06-06
WO2001049851A1 (en) 2001-07-12
AU784361B2 (en) 2006-03-16
CN1406280A (zh) 2003-03-26
DE69926920T2 (de) 2006-06-29
DE69926920D1 (de) 2005-09-29
JP2003521900A (ja) 2003-07-22
EP1246919A1 (en) 2002-10-09
AU784361C (en) 2007-03-15
ATE302848T1 (de) 2005-09-15
CA2395625A1 (en) 2001-07-12
AU2401400A (en) 2001-07-16

Similar Documents

Publication Publication Date Title
ATE302848T1 (de) Stammzellen schutzfaktor und verwandte methoden und produkte
ATE311894T1 (de) Verfahren zur herstellung von konditionierten zellkulturmedium-zusammensetzungen
WO2001023592A3 (en) Methods for making recombinant proteins using apoptosis inhibitors
MY148759A (en) Methods to culture circovirus
DE69734605D1 (de) Abgeschwächter salmonellenstamm, gebraucht als vehikel zur oralen immunisierung
IL137361A0 (en) Inhibitors of the cd40 ligand-cd40 interaction
AU4981101A (en) Subtilisin variants
DE3161494D1 (en) Cosmetic preparations
AU5886000A (en) Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells
JP2002517227A5 (ja) 造血幹細胞を試験管内で維持する方法と組成物
PL336983A1 (en) Compounds, their production and application as carriers of nucleic acids in cells
DK1115840T3 (da) Afstamningsspecifikke celler og progenitorceller
MXPA03005548A (es) Metodos para la produccion de proteinas multimericas, y composiciones relacionadas.
YU19499A (sh) Benzonaftiridini kao bronhijalni terapeutici
TW200505501A (en) CCI-779 lyophilized formulations
AU6745287A (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors, biotechnological methods for the preparation of said proteins and pharmaceutical compositions containing said proteins
AU5168099A (en) Use of novel agents inducing cell death in synergy with interferons
AU4299696A (en) Use of the hepatocyte growth factor to induce proliferation and differentiation of hemopoietic cells
MXPA03004539A (es) Luciferasas aisladas y uso de las mismas.
GB2379446A (en) Cells,culture methods and their uses
HUP0102413A1 (hu) Vektorok nukleinsavak bevitelére, ezeket tartalmazó készítmények és alkalmazásuk
AU1248602A (en) Formulations comprising dextrin polymers in combination with sugars for the delivery of nucleic acids
MXPA02011592A (es) Composiciones de celulas dendriticas circulantes, humanas y metodos.
NZ514027A (en) Cloning and expression of haemophilus somnus transferrin-binding proteins
EP0925064A4 (en) 5-ANDROSTEN 3-beta, 17-alpha DIOL AS A TUMOR GROWTH INHIBITOR